Dr. Kadalmani Krishnan shares insights from cutting-edge research that is reimagining healthcare and reshaping how we tackle some of the world’s most pressing global challenges—offering innovative perspectives at the intersection of science, technology, and humanity. Dr. Kadalmani Krishnan is a visionary leader in biotechnology with over 20 years of experience in turning science into real-world healthcare solutions. With a Ph.D. from the University of Cambridge and postdoctoral research at Harvard Medical School, he blends deep scientific knowledge with practical innovation. As the CEO of Thrafford Lifescience, Dr. Krishnan is leading efforts to make cutting-edge treatments—like cell therapy—more accessible to people everywhere. He played a key role in developing India’s first GLP-RA biosimilar and helped secure major funding to support new medicines and manufacturing facilities. Dr. Krishnan’s expertise spans drug development, clinical trials, regulatory strategy, and business leadership. He has advised top pharmaceutical companies and government bodies, shaping policies and guiding breakthrough projects in cancer, immune disorders, and diabetes. Driven by a deep love for teaching, he actively mentors young scientists and entrepreneurs—igniting minds with the spirit of disruptive innovation. Also, widely recognized for his contributions, Dr. Krishnan continues to build bridges between science, strategy, and public health—working to bring high-quality treatments to those who need them most. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx